Portrait of Dr. Julie Forman-Kay

Julie Forman-Kay

Program head
Hospital for Sick Children

Julie Forman-Kay is program head in molecular medicine at the Hospital for Sick Children in Toronto, Canada. She received her B.Sc. in chemistry from the Massachusetts Institute of Technology and her Ph.D. in molecular biophysics andd biochemistry from Yale University. The major focus of her lab is to provide biological insights into how dynamic properties of proteins are related to function and methodological tools to enable better understanding of dynamic and disordered states. Most recently, her lab has probed the biophysics of protein phase separation and how it regulates cellular condensates and biological function.

From this contributor

Explore more from The Transmitter

Ilustração de canto de pássaro, cérebro de pássaro e DNA.

Este artigo mudou minha vida: adotando um dos primeiros modelos de neurociência naturalística

Um artigo publicado na PNAS em 1992 mostrou que o canto das aves aumenta a expressão de um gene de resposta imediata no prosencéfalo dessas aves. O estudo revelou a Ribeiro a importância de investigar as respostas moleculares em contextos naturalísticos.

By Sidarta Ribeiro
3 August 2026 | 5 min read
Ilustración del canto de las aves, el cerebro de las aves y el ADN.

Este artículo cambió mi vida: Adoptando un modelo temprano de neurociencia naturalista

Un estudio del 1992 publicado en PNAS demostró que el canto de las aves aumenta la expresión de un gen de respuesta temprana inmediata en el prosencéfalo de los pájaros. El trabajo le reveló a Ribeiro la importancia de estudiar las respuestas moleculares en contextos naturalistas.

By Sidarta Ribeiro
3 August 2026 | 5 min read
Illustration of scientists climbing over a barrier to reach publications.

Scientific talent is global. Access to the world’s scientific stage is not.

Neuroscience in Chile, and across Latin America, does not lack talent or ideas, but the systems that make science visible—prestigious journals, conferences and networks—increasingly price its researchers out.

By Vicente Medel
3 August 2026 | 8 min read